|

Interview With Dr. Hyder A. Khoja

Dr. Hyder A. Khoja

Similar Posts

  • Is it TOO LATE to Buy MindMed (MMED) 🍄: Part deux (Plus Clinical Trial Updates!)

    Is it TOO LATE to Buy MindMed (MMED / MMEDF)? NO! Of course not. We are at the beginning of the Psychedelic Stocks boom. Despite the recent MASSIVE runup, the stock has skyrocketed more than 4x in the last week (due to a possible inclusion into the Nasdaq, clinical trial updates and hype), MindMed still has a long way to go yet. MMEDF is definitely one of the best stocks for 2021
    Hope you guys enjoy this video!

    Note, the stock has dropped a bit since filming, but everything still holds. Plus, I’m sure it will clear that 4 dollar mark again within days!

    Follow us on social media!
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
    Resources:
    https://www.thestreet.com/investing/n…
    https://www.prnewswire.com/news-relea…

    #MindMed #MMED #mindmedstock #MMEDF #PsychedelicStocks #PennyStocks #Investing #BestStocksFor2021

  • Psychedelics Aiding Recovery with Arrowyn Ambrose

    In this episode, Arrowyn speaks on how psychedelics are integrated into recovery and addiction, how community can profoundly impact those in recovery, and how we can assist those who are in need of psychedelic therapy but may not have access.